| Year |
Citation |
Score |
| 2024 |
Sillau SH, Coughlan C, Ahmed MM, Nair K, Araya P, Galbraith MD, Bettcher BM, Espinosa JM, Chial HJ, Epperson N, Boyd TD, Potter H. Neuron loss in the brain starts in childhood, increases exponentially with age and is halted by GM-CSF treatment in Alzheimer's disease. Medrxiv : the Preprint Server For Health Sciences. PMID 39072024 DOI: 10.1101/2024.07.14.24310223 |
0.746 |
|
| 2024 |
Coughlan C, Lindenberger J, Jacot JG, Johnson NR, Anton P, Bevers S, Welty R, Graner MW, Potter H. Specific Binding of Alzheimer's Aβ Peptides to Extracellular Vesicles. International Journal of Molecular Sciences. 25. PMID 38612514 DOI: 10.3390/ijms25073703 |
0.336 |
|
| 2024 |
James E, Vielle A, Cusato K, Li H, Lee B, Parween S, Howell A, Johnson NR, Chial HJ, Potter H, Vergara MN. Human iPSC-derived retinal organoids develop robust Alzheimer's disease neuropathology. Frontiers in Cellular Neuroscience. 18: 1340448. PMID 38323188 DOI: 10.3389/fncel.2024.1340448 |
0.363 |
|
| 2023 |
Thaker AA, McConnell BV, Rogers DM, Carlson NE, Coughlan C, Jensen AM, Lopez-Paniagua D, Holden SK, Pressman PS, Pelak VS, Filley CM, Potter H, Adriana Solano D, Heffernan KS, Bettcher BM. Astrogliosis, neuritic microstructure, and sex effects: GFAP is an indicator of neuritic orientation in women. Brain, Behavior, and Immunity. PMID 37394144 DOI: 10.1016/j.bbi.2023.06.026 |
0.345 |
|
| 2023 |
Stonedahl S, Leser JS, Clarke P, Potter H, Boyd TD, Tyler KL. Treatment with Granulocyte-Macrophage Colony-Stimulating Factor Reduces Viral Titers in the Brains of West Nile Virus-Infected Mice and Improves Survival. Journal of Virology. e0180522. PMID 36802227 DOI: 10.1128/jvi.01805-22 |
0.716 |
|
| 2022 |
Lucero EM, Freund RK, Smith A, Johnson NR, Dooling B, Sullivan E, Prikhodko O, Ahmed MM, Bennett DA, Hohman TJ, Dell'Acqua ML, Chial HJ, Potter H. Increased / expression offsets Alzheimer Aβ-mediated toxicity and cognitive dysfunction. Iscience. 25: 105288. PMID 36304124 DOI: 10.1016/j.isci.2022.105288 |
0.347 |
|
| 2022 |
Johnson NR, Wang AC, Coughlan C, Sillau S, Lucero E, Viltz L, Markham N, Allen C, Dhanasekaran AR, Chial HJ, Potter H. Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer's disease cognition. Alzheimer's Research & Therapy. 14: 88. PMID 35768831 DOI: 10.1186/s13195-022-01020-9 |
0.366 |
|
| 2022 |
Ahmed MM, Wang AC, Elos M, Chial HJ, Sillau S, Solano DA, Coughlan C, Aghili L, Anton P, Markham N, Adame V, Gardiner KJ, Boyd TD, Potter H. The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 down syndrome mice and improves learning/memory in wild-type mice. Neurobiology of Disease. 105694. PMID 35307513 DOI: 10.1016/j.nbd.2022.105694 |
0.761 |
|
| 2022 |
Galvin J, Curran E, Arteaga F, Goossens A, Aubuchon-Endsley N, McMurray MA, Moore J, Hansen KC, Chial HJ, Potter H, Brodsky JL, Coughlan CM. Proteasome activity modulates amyloid toxicity. Fems Yeast Research. PMID 35150241 DOI: 10.1093/femsyr/foac004 |
0.322 |
|
| 2022 |
Potter H, Kendall L, Boyd T, Sillau S, Bosco-Lauth A, Markham N, Fong D, Clarke P, Tyler K. GM-CSF Promotes Immune Response and Survival in a Mouse Model of COVID-19. Research Square. PMID 35118463 DOI: 10.21203/rs.3.rs-1213395/v1 |
0.72 |
|
| 2021 |
Ahmed MM, Johnson NR, Boyd TD, Coughlan C, Chial HJ, Potter H. Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners? Frontiers in Aging Neuroscience. 13: 718426. PMID 34603007 DOI: 10.3389/fnagi.2021.718426 |
0.732 |
|
| 2021 |
Potter H, Woodcock JH, Boyd TD, Coughlan CM, O'Shaughnessy JR, Borges MT, Thaker AA, Raj BA, Adamszuk K, Scott D, Adame V, Anton P, Chial HJ, Gray H, Daniels J, et al. Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 7: e12158. PMID 33778150 DOI: 10.1002/trc2.12158 |
0.771 |
|
| 2020 |
Bubak AN, Beseler C, Como CN, Coughlan CM, Johnson NR, Hassell JE, Burnet AM, Mescher T, Schmid DS, Coleman C, Mahalingam R, Cohrs RJ, Boyd TD, Potter H, Shilleh AH, et al. Amylin, Aβ42, and Amyloid in VZV Vasculopathy Cerebrospinal Fluid and Infected Vascular Cells. The Journal of Infectious Diseases. PMID 32809013 DOI: 10.1093/Infdis/Jiaa513 |
0.74 |
|
| 2020 |
Potter H, Boyd TD, Clarke P, Pelak VS, Tyler KL. Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19. F1000research. 9: 345. PMID 32704352 DOI: 10.12688/F1000Research.23729.1 |
0.745 |
|
| 2020 |
Coughlan C, Bruce KD, Burgy O, Boyd TD, Michel CR, Garcia-Perez JE, Adame V, Anton P, Bettcher BM, Chial HJ, Koenigshoff M, Hsieh EWY, Graner M, Potter H. Exosome Isolation by Ultracentrifugation and Precipitation and Techniques for Downstream Analyses. Current Protocols in Cell Biology. 88: e110. PMID 32633898 DOI: 10.1002/Cpcb.110 |
0.69 |
|
| 2020 |
Snyder HM, Bain LJ, Brickman AM, Carrillo MC, Esbensen AJ, Espinosa JM, Fernandez F, Fortea J, Hartley SL, Head E, Hendrix J, Kishnani PS, Lai F, Lao P, Lemere C, ... ... Potter H, et al. Further understanding the connection between Alzheimer's disease and Down syndrome. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32544310 DOI: 10.1002/Alz.12112 |
0.407 |
|
| 2020 |
Bubak AN, Beseler C, Como CN, Tyring SK, Haley C, Mescher T, Hassell JE, Cohrs RJ, Potter H, Nagel MA. Acute zoster plasma contains elevated amyloid, correlating with Aβ42 and amylin levels, and is amyloidogenic. Journal of Neurovirology. PMID 32385803 DOI: 10.1007/S13365-020-00830-7 |
0.408 |
|
| 2019 |
Potter H, Chial HJ, Caneus J, Elos M, Elder N, Borysov S, Granic A. Chromosome Instability and Mosaic Aneuploidy in Neurodegenerative and Neurodevelopmental Disorders. Frontiers in Genetics. 10: 1092. PMID 31788001 DOI: 10.3389/Fgene.2019.01092 |
0.331 |
|
| 2019 |
Bubak AN, Como CN, Coughlan CM, Johnson NR, Hassell JE, Mescher T, Niemeyer CS, Mahalingam R, Cohrs RJ, Boyd TD, Potter H, Russ HA, Nagel MA. Varicella Zoster Virus Infection of Primary Human Spinal Astrocytes Produces Intracellular Amylin, Amyloid-beta, and an Amyloidogenic Extracellular Environment. The Journal of Infectious Diseases. PMID 31665341 DOI: 10.1093/Infdis/Jiz560 |
0.744 |
|
| 2019 |
Potter H, Chial HJ. Targeting the Interaction Between Apolipoprotein E and Amyloid Precursor Protein: A Novel Alzheimer's Disease Therapy. Biological Psychiatry. 86: 169-170. PMID 31319935 DOI: 10.1016/J.Biopsych.2019.06.005 |
0.384 |
|
| 2019 |
Pelak VS, Tang-Wai DF, Bouwman FH, Onyike CU, Murray ME, Day GS, Migliaccio R, Olds J, Hills W, Bretsch C, Lusk J, Potter H, Boyd T, Pressman PS, Holden SK, et al. P1-311: Development Of An International Posterior Cortical Atrophy Bioregistry Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.866 |
0.691 |
|
| 2019 |
Ahmed MM, Jung Wang AC, Boyd T, Elos M, Chial HJ, Gardiner KJ, Potter H. P4-032: GM-CSF REVERSES MEMORY DEFICITS IN NORMAL AGED MICE AND IN THE DP(16)1YEY MOUSE MODEL OF DOWN SYNDROME Alzheimer's & Dementia. 15: P1286-P1287. DOI: 10.1016/J.Jalz.2019.06.3691 |
0.304 |
|
| 2017 |
Caneus J, Granic A, Rademakers R, Dickson DW, Coughlan CM, Chial HJ, Potter H. Mitotic Defects Lead to Neuronal Aneuploidy and Apoptosis in Frontotemporal Lobar Degeneration Caused by MAPT Mutations. Molecular Biology of the Cell. PMID 29282277 DOI: 10.1091/Mbc.E17-01-0031 |
0.321 |
|
| 2017 |
Hamlett ED, Ledreux A, Potter H, Chial HJ, Patterson D, Espinosa JM, Bettcher BM, Granholm AC. EXOSOMAL BIOMARKERS IN DOWN SYNDROME AND ALZHEIMER'S DISEASE. Free Radical Biology & Medicine. PMID 28882786 DOI: 10.1016/J.Freeradbiomed.2017.08.028 |
0.449 |
|
| 2017 |
Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Potter H, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916 |
0.348 |
|
| 2017 |
Potter H, Woodcock JH, Boyd T, Sillau SH, Bettcher BM, Daniels J, Heffernan KS, Gray H. INTERIM REPORT OF A PHASE 2 PILOT SAFETY AND EFFICACY TRIAL OF GM-CSF/LEUKINE® IN MILD-TO-MODERATE ALZHEIMER'S DISEASE Alzheimer's & Dementia. 13: P1572. DOI: 10.1016/J.Jalz.2017.07.735 |
0.74 |
|
| 2017 |
Coughlan CM, Wang A, Viltz L, Chial HJ, Potter H. [P2-143]: SCREENING FOR INHIBITORS OF APOE4-CATALYZED Aβ OLIGOMER/FILAMENT FORMATION: A NOVEL APPROACH TO ALZHEIMER's DISEASE DRUG DISCOVERY Alzheimer's & Dementia. 13: P662-P663. DOI: 10.1016/J.Jalz.2017.06.793 |
0.372 |
|
| 2016 |
Potter H. New Genetic Links Between Alzheimer Disease and Immune-Mediated Diseases Revealed by Overlapping Genome-wide Association Study Hits. Jama Neurology. PMID 27088554 DOI: 10.1001/Jamaneurol.2016.0407 |
0.338 |
|
| 2016 |
Freund RK, Gibson ES, Potter H, Dell'Acqua ML. Inhibition of the motor protein Eg5/Kinesin-5 in amyloid beta-mediated impairment of hippocampal long-term potentiation and dendritic spine loss. Molecular Pharmacology. PMID 26957206 DOI: 10.1124/Mol.115.103085 |
0.336 |
|
| 2016 |
Potter H, Granic A, Caneus J. Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease. Current Alzheimer Research. 13: 7-17. PMID 26651340 DOI: 10.2174/156720501301151207100616 |
0.46 |
|
| 2016 |
Caneus J, Potter H. P2-114: Increased Genomic Instability and Correlated Apoptosis are Associated with Cognitive Impairment in Neurodegenerative Diseases Alzheimer's & Dementia. 12: P655-P656. DOI: 10.1016/J.Jalz.2016.06.1484 |
0.341 |
|
| 2015 |
Potter H. Kinesin light chain-1 variant E disrupts axonal transport and Aβ generation in Alzheimer's disease (comment on DOI 10.1002/bies.201400131). Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 37: 118. PMID 25581896 DOI: 10.1002/Bies.201400206 |
0.33 |
|
| 2015 |
Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Potter H, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/Jamaneurol.2014.2157 |
0.438 |
|
| 2015 |
Hartley D, Blumenthal T, Carrillo M, DiPaolo G, Esralew L, Gardiner K, Granholm AC, Iqbal K, Krams M, Lemere C, Lott I, Mobley W, Ness S, Nixon R, Potter H, et al. Down syndrome and Alzheimer's disease: Common pathways, common goals. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 700-9. PMID 25510383 DOI: 10.1016/J.Jalz.2014.10.007 |
0.433 |
|
| 2015 |
Caneus J, Potter H. P1-006: Association of aneuploidy with multiple neurodegenerative diseases and its possible involvement in the progression of cognitive decline Alzheimer's & Dementia. 11: P338-P338. DOI: 10.1016/J.Jalz.2015.06.202 |
0.367 |
|
| 2014 |
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Potter H, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/Jamaneurol.2014.1491 |
0.341 |
|
| 2014 |
Ari C, Borysov SI, Wu J, Padmanabhan J, Potter H. Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function. Neurobiology of Aging. 35: 1839-49. PMID 24636920 DOI: 10.1016/J.Neurobiolaging.2014.02.006 |
0.414 |
|
| 2014 |
Wang A, Potter H, Bennett S, Caneus J, Ari C, Borysov S, Padmanabhan J, Wu J, Granic A. P2-011: Aβ INHIBITION OF KINESIN 5 DISRUPTS THE LOCALIZATION AND FUNCTION OF MEMBRANE PROTEINS: IMPLICATIONS FOR NEURONAL RESPONSES TO NEUROTROPHINS, NEUROTRANSMITTERS, GLUCOSE, AND LIPIDS IN AD Alzheimer's & Dementia. 10: P474-P474. DOI: 10.1016/J.Jalz.2014.05.684 |
0.329 |
|
| 2013 |
Duara R, Loewenstein DA, Shen Q, Barker W, Varon D, Greig MT, Curiel R, Agron J, Santos I, Potter H. The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer's disease, MCI and cognitively normal elderly subjects. Frontiers in Aging Neuroscience. 5: 47. PMID 24065917 DOI: 10.3389/Fnagi.2013.00047 |
0.427 |
|
| 2013 |
Granic A, Potter H. Mitotic spindle defects and chromosome mis-segregation induced by LDL/cholesterol-implications for Niemann-Pick C1, Alzheimer's disease, and atherosclerosis. Plos One. 8: e60718. PMID 23593294 DOI: 10.1371/Journal.Pone.0060718 |
0.358 |
|
| 2012 |
Nilsson LN, Gografe S, Costa DA, Hughes T, Dressler D, Potter H. USE OF FUSED CIRCULATIONS TO INVESTIGATE THE ROLE OF APOLIPOPROTEIN E AS AMYLOID CATALYST AND PERIPHERAL SINK IN ALZHEIMER'S DISEASE. Technology and Innovation. 14: 199-208. PMID 23626867 DOI: 10.3727/194982412X13462021398010 |
0.706 |
|
| 2012 |
Shen Q, Zhao W, Loewenstein DA, Potter E, Greig MT, Raj A, Barker W, Potter H, Duara R. Comparing new templates and atlas-based segmentations in the volumetric analysis of brain magnetic resonance images for diagnosing Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 399-406. PMID 22959698 DOI: 10.1016/J.Jalz.2011.07.002 |
0.356 |
|
| 2012 |
Jim HS, Boyd TD, Booth-Jones M, Pidala J, Potter H. Granulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients. Brain Disorders & Therapy. 1. PMID 22905341 DOI: 10.4172/2168-975X.1000101 |
0.745 |
|
| 2012 |
Potter H, Wisniewski T. Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascade. International Journal of Alzheimer's Disease. 2012: 489428. PMID 22844635 DOI: 10.1155/2012/489428 |
0.435 |
|
| 2012 |
Loewenstein DA, Greig MT, Schinka JA, Barker W, Shen Q, Potter E, Raj A, Brooks L, Varon D, Schoenberg M, Banko J, Potter H, Duara R. An investigation of PreMCI: subtypes and longitudinal outcomes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 172-9. PMID 22546351 DOI: 10.1016/J.Jalz.2011.03.002 |
0.314 |
|
| 2012 |
Cao C, Loewenstein DA, Lin X, Zhang C, Wang L, Duara R, Wu Y, Giannini A, Bai G, Cai J, Greig M, Schofield E, Ashok R, Small B, Potter H, et al. High Blood caffeine levels in MCI linked to lack of progression to dementia. Journal of Alzheimer's Disease : Jad. 30: 559-72. PMID 22430531 DOI: 10.3233/Jad-2012-111781 |
0.342 |
|
| 2012 |
Boyd TD, Potter H. THE JOURNEY OF A POTENTIAL ALZHEIMER THERAPY FROM THE LABORATORY BENCH THROUGH THE PATENT OFFICE AND INTO THE CLINIC Technology & Innovation. 14: 365-380. DOI: 10.3727/194982412X13500042169216 |
0.725 |
|
| 2012 |
Granic A, Norden M, Potter H. P2-085: Genomic damage induced by lipoproteins/cholesterol: Implications for Alzheimer's and cardiovascular disease Alzheimer's & Dementia. 8: P293-P293. DOI: 10.1016/J.Jalz.2012.05.789 |
0.34 |
|
| 2012 |
Cao C, Lin X, Wang W, Li Y, Cai J, Raj B, Potter H. P2-004: The role of CD8 T cell and its receptor change in Alzheimer's disease Alzheimer's & Dementia. 8: P265-P265. DOI: 10.1016/J.Jalz.2012.05.707 |
0.313 |
|
| 2011 |
Judge M, Hornbeck L, Potter H, Padmanabhan J. Mitosis-specific phosphorylation of amyloid precursor protein at threonine 668 leads to its altered processing and association with centrosomes. Molecular Neurodegeneration. 6: 80. PMID 22112898 DOI: 10.1186/1750-1326-6-80 |
0.424 |
|
| 2011 |
Shen Q, Loewenstein DA, Potter E, Zhao W, Appel J, Greig MT, Raj A, Acevedo A, Schofield E, Barker W, Wu Y, Potter H, Duara R. Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: e101-8. PMID 21784342 DOI: 10.1016/J.Jalz.2010.07.002 |
0.405 |
|
| 2011 |
Borysov SI, Granic A, Padmanabhan J, Walczak CE, Potter H. Alzheimer Aβ disrupts the mitotic spindle and directly inhibits mitotic microtubule motors. Cell Cycle (Georgetown, Tex.). 10: 1397-410. PMID 21566458 DOI: 10.4161/Cc.10.9.15478 |
0.32 |
|
| 2011 |
Varon D, Loewenstein DA, Potter E, Greig MT, Agron J, Shen Q, Zhao W, Celeste Ramirez M, Santos I, Barker W, Potter H, Duara R. Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment. Dementia and Geriatric Cognitive Disorders. 31: 276-83. PMID 21494034 DOI: 10.1159/000324711 |
0.328 |
|
| 2011 |
Duara R, Loewenstein DA, Greig MT, Potter E, Barker W, Raj A, Schinka J, Borenstein A, Schoenberg M, Wu Y, Banko J, Potter H. Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 19: 951-60. PMID 21422909 DOI: 10.1097/Jgp.0B013E3182107C69 |
0.334 |
|
| 2011 |
Potter H. Alzheimer's insight New Scientist. 211: 32. DOI: 10.1016/S0262-4079(11)61900-3 |
0.407 |
|
| 2011 |
Potter H, Jim H, Boyd T, Booth-Jones M, Pidala J. O3-07-07: Potential Alzheimer's treatments GM-CSF and G-CSF improve cognition in cancer patients Alzheimer's & Dementia. 7: S514-S514. DOI: 10.1016/J.Jalz.2011.05.1438 |
0.353 |
|
| 2010 |
Schinka JA, Loewenstein DA, Raj A, Schoenberg MR, Banko JL, Potter H, Duara R. Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 18: 684-91. PMID 21399729 DOI: 10.1097/Jgp.0B013E3181E56D5A |
0.344 |
|
| 2010 |
Boyd TD, Bennett SP, Mori T, Governatori N, Runfeldt M, Norden M, Padmanabhan J, Neame P, Wefes I, Sanchez-Ramos J, Arendash GW, Potter H. GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. Journal of Alzheimer's Disease : Jad. 21: 507-18. PMID 20555144 DOI: 10.3233/Jad-2010-091471 |
0.782 |
|
| 2010 |
Duara R, Loewenstein DA, Greig M, Acevedo A, Potter E, Appel J, Raj A, Schinka J, Schofield E, Barker W, Wu Y, Potter H. Reliability and validity of an algorithm for the diagnosis of normal cognition, mild cognitive impairment, and dementia: implications for multicenter research studies. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 18: 363-70. PMID 20306566 DOI: 10.1097/Jgp.0B013E3181C534A0 |
0.354 |
|
| 2010 |
Abisambra JF, Fiorelli T, Padmanabhan J, Neame P, Wefes I, Potter H. LDLR expression and localization are altered in mouse and human cell culture models of Alzheimer's disease. Plos One. 5: e8556. PMID 20049331 DOI: 10.1371/Journal.Pone.0008556 |
0.714 |
|
| 2010 |
Granic A, Padmanabhan J, Norden M, Potter H. Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP. Molecular Biology of the Cell. 21: 511-20. PMID 20032300 DOI: 10.1091/Mbc.E09-10-0850 |
0.446 |
|
| 2010 |
Schinka JA, Raj A, Loewenstein DA, Small BJ, Duara R, Potter H. Cross-validation of the Florida Cognitive Activities Scale (FCAS) in an Alzheimer's disease research center sample. Journal of Geriatric Psychiatry and Neurology. 23: 9-14. PMID 19703991 DOI: 10.1177/0891988709342724 |
0.368 |
|
| 2010 |
Schinka JA, Raj A, Loewenstein DA, Small BJ, Duara R, Potter H. The cognitive change checklist (3CL): cross-validation of a measure of change in everyday cognition. International Journal of Geriatric Psychiatry. 25: 266-74. PMID 19575419 DOI: 10.1002/Gps.2332 |
0.342 |
|
| 2010 |
Duara R, Loewenstein DA, Greig-Custo MT, Raj A, Barker W, Potter E, Schofield E, Small B, Schinka J, Wu Y, Potter H. Diagnosis and staging of mild cognitive impairment, using a modification of the clinical dementia rating scale: the mCDR. International Journal of Geriatric Psychiatry. 25: 282-9. PMID 19565573 DOI: 10.1002/Gps.2334 |
0.339 |
|
| 2010 |
Potter H, Granic A, Borysov S, Abisambra JF, Padmanabhan J, Wefes I, Goodwin B, Neame P, Fiorelli T, Norden M. P4-005: Alzheimer Aβ Induces Chromosome Mis-segregation, Microtubule Defects, Receptor Mis-localization, and Inhibition of Mitotic/Neuronal Kinesins: Implications for Neurogenesis and Plasticity in Neurodegenrative Diseases Alzheimer's & Dementia. 6: e22-e22. DOI: 10.1016/J.Jalz.2010.08.066 |
0.67 |
|
| 2010 |
Varon D, Potter E, Rodriguez M, Barker W, Raj BA, Loewenstein D, Potter H, Duara R. Correlating minimal atrophy of hippocampus (HPC) and entorhinal cortex (ERC) with memory and functional ability among elderly subjects Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.023 |
0.363 |
|
| 2009 |
Bennett SP, Boyd TD, Norden M, Padmanabhan J, Neame P, Wefes I, Potter H. A novel technique for simultaneous bilateral brain infusions in a mouse model of neurodegenerative disease. Journal of Neuroscience Methods. 184: 320-6. PMID 19732796 DOI: 10.1016/J.Jneumeth.2009.08.021 |
0.779 |
|
| 2009 |
Appel J, Potter E, Bhatia N, Shen Q, Zhao W, Greig MT, Raj A, Barker WW, Potter H, Schofield E, Wu Y, Loewenstein DA, Duara R. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors. Ajnr. American Journal of Neuroradiology. 30: 1870-6. PMID 19643919 DOI: 10.3174/Ajnr.A1693 |
0.391 |
|
| 2009 |
Cao C, Cirrito JR, Lin X, Wang L, Wang L, Verges DK, Dickson A, Mamcarz M, Zhang C, Mori T, Arendash GW, Holtzman DM, Potter H. Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. Journal of Alzheimer's Disease : Jad. 17: 681-97. PMID 19581723 DOI: 10.3233/Jad-2009-1071 |
0.461 |
|
| 2009 |
Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. Journal of Alzheimer's Disease : Jad. 17: 661-80. PMID 19581722 DOI: 10.3233/Jad-2009-1087 |
0.746 |
|
| 2008 |
Duara R, Loewenstein DA, Potter E, Appel J, Greig MT, Urs R, Shen Q, Raj A, Small B, Barker W, Schofield E, Wu Y, Potter H. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology. 71: 1986-92. PMID 19064880 DOI: 10.1212/01.Wnl.0000336925.79704.9F |
0.406 |
|
| 2008 |
Cao C, Lin X, Zhang C, Wahi MM, Wefes I, Arendash G, Potter H. Mutant amyloid-beta-sensitized dendritic cells as Alzheimer's disease vaccine. Journal of Neuroimmunology. 200: 1-10. PMID 18649951 DOI: 10.1016/J.Jneuroim.2008.05.017 |
0.305 |
|
| 2008 |
Cao C, Lin X, Wahi MM, Jackson EA, Potter H. Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides. Bmc Neuroscience. 9: 25. PMID 18282292 DOI: 10.1186/1471-2202-9-25 |
0.319 |
|
| 2008 |
Leighty RE, Runfeldt MJ, Berndt DJ, Schleif WS, Cracchiolo JR, Potter H, Arendash GW. Use of artificial neural networks to determine cognitive impairment and therapeutic effectiveness in Alzheimer's transgenic mice. Journal of Neuroscience Methods. 167: 358-66. PMID 17904642 DOI: 10.1016/J.Jneumeth.2007.08.008 |
0.805 |
|
| 2008 |
Boeras DI, Granic A, Padmanabhan J, Crespo NC, Rojiani AM, Potter H. Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy. Neurobiology of Aging. 29: 319-28. PMID 17169464 DOI: 10.1016/J.Neurobiolaging.2006.10.027 |
0.733 |
|
| 2008 |
Arendash GW, Mamcarz M, Dickson A, Wang L, Xiaoyang L, Cao C, Potter H. P1-068: Environmental enrichment “sessions” are sufficient to provide cognitive benefit to impaired Alzheimer's transgenic mice without affecting brain or plasma Aβ levels Alzheimer's & Dementia. 4: T226-T226. DOI: 10.1016/J.Jalz.2008.05.654 |
0.447 |
|
| 2008 |
Cao C, Lin X, Zhang C, Breitenkamp K, Wang L, Dillingham C, Potter H. O3-05-06: Nanoparticle Alzheimer's disease vaccine targeting oligomeric Abeta Alzheimer's & Dementia. 4: T169-T169. DOI: 10.1016/J.Jalz.2008.05.446 |
0.333 |
|
| 2008 |
Arendash GW, Cao C, Mori T, Mamcartz M, Dickson A, Wang L, Runfelt M, Rezai-zadeh K, Tan J, Xiaoyang L, Potter H. O1-04-04: Caffeine reverses cognitive impairment, decreases β-amyloid levels, and reduces inflammation in aged Alzheimer's mice: Implications for Alzheimer's treatment Alzheimer's & Dementia. 4: T115-T115. DOI: 10.1016/J.Jalz.2008.05.241 |
0.731 |
|
| 2008 |
Granic A, Potter H. P4-302: Lipoprotein-induced chromosome missegregation in vitro
and in vivo:
Implications for cardiovascular and Alzheimer's disease Alzheimer's & Dementia. 4: T760-T760. DOI: 10.1016/J.Jalz.2008.05.2372 |
0.359 |
|
| 2008 |
Cao C, Lin X, Zhang C, Dickson A, Mamcarz M, Wang L, Arendash G, Potter H. IC-P3-174: Plasma Aβ level can be used as marker for AD treatment in PS1/APP Alzheimer's mouse model Alzheimer's & Dementia. 4: T77-T77. DOI: 10.1016/J.Jalz.2008.05.118 |
0.303 |
|
| 2008 |
Potter H, Granic A, Boeras D, Crespo N, Padmanabhan J. P1-432: Alzheimer's mutant presenilin-1 and amyloid precursor protein genes cause chromosome missegregation and aneuploidy through the action of Abeta peptide Alzheimer's & Dementia. 4: T346-T346. DOI: 10.1016/J.Jalz.2008.05.1014 |
0.385 |
|
| 2007 |
Arendash GW, Jensen MT, Salem N, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Neuroscience. 149: 286-302. PMID 17904756 DOI: 10.1016/J.Neuroscience.2007.08.018 |
0.791 |
|
| 2007 |
Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J, Hubbard JL, Koepsell TD, Morris JC, Kukull WA, Reiman EM, Kowall N, Landreth G, Shelanski M, Welsh-Bohmer K, ... ... Potter H, et al. The National Alzheimer's Coordinating Center (NACC) database: The uniform data set Alzheimer Disease and Associated Disorders. 21: 249-258. PMID 17804958 DOI: 10.1097/Wad.0B013E318142774E |
0.329 |
|
| 2007 |
Cracchiolo JR, Mori T, Nazian SJ, Tan J, Potter H, Arendash GW. Enhanced cognitive activity--over and above social or physical activity--is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity. Neurobiology of Learning and Memory. 88: 277-94. PMID 17714960 DOI: 10.1016/J.Nlm.2007.07.007 |
0.405 |
|
| 2007 |
Costa DA, Cracchiolo JR, Bachstetter AD, Hughes TF, Bales KR, Paul SM, Mervis RF, Arendash GW, Potter H. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiology of Aging. 28: 831-44. PMID 16730391 DOI: 10.1016/J.Neurobiolaging.2006.04.009 |
0.694 |
|
| 2007 |
Arendash GW, Rezai-Zadeh K, Cao C, Mamcarz M, Dickson A, Schleif W, Runfeldt M, Lin X, Cracchiolo J, Shippy D, Raj A, Tan J, Potter H. O1-01-01: Caffeine: Evidence for protection against, and treatment for, Alzheimer's disease by direct suppression of disease pathogenesis Alzheimer's & Dementia. 3: S166-S166. DOI: 10.1016/J.Jalz.2007.04.355 |
0.695 |
|
| 2007 |
Potter H. S3-01-01: From diet and lifstyle factors to Alzheimer's mechanism and treatment Alzheimer's & Dementia. 3: S198-S198. DOI: 10.1016/J.Jalz.2007.04.008 |
0.332 |
|
| 2006 |
Padmanabhan J, Levy M, Dickson DW, Potter H. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Brain : a Journal of Neurology. 129: 3020-34. PMID 16987932 DOI: 10.1093/Brain/Awl255 |
0.442 |
|
| 2006 |
Boyd T, Woodcock JH, Adame V, Sillau SH, Borges TT, Bettcher BM, Daniels J, Heffernan KS, Potter H. P4-203: INTERIM BIOMARKER ANALYSES OF PHASE II STUDY DATA ON SAFETY AND EFFICACY OF GM-CSF/LEUKINE®
IN MILD-TO-MODERATE AD Alzheimer's & Dementia. 14: P1517-P1518. DOI: 10.1016/J.Jalz.2018.07.024 |
0.731 |
|
| 2006 |
Potter H, Woodcock JH, Boyd T, Sillau SH, Borges TT, Bettcher BM, Daniels J, Heffernan KS. O1-12-01: PHASE II STUDY DATA ON SAFETY AND EFFICACY OF GM-CSF/LEUKINE®
IN MILD-TO-MODERATE ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P249-P249. DOI: 10.1016/J.Jalz.2018.06.2396 |
0.342 |
|
| 2006 |
Caneus J, Elos M, Potter H. P1-213: ELEVATED LEVELS OF MOSAIC ANEUPLOIDY IN HUNTINGTON'S DISEASE Alzheimer's & Dementia. 14: P360-P361. DOI: 10.1016/J.Jalz.2018.06.218 |
0.319 |
|
| 2006 |
Arndash GW, Cracchiolo JR, Costa DA, Mori T, Hughes TF, Bales KR, Paul SM, Potter H. P4-322: Complete environmental enrichment is required to protect AD transgenic mice against cognitive impairment, reduce a-beta deposition, and increase synaptophysin staining: Involvement of both amyloid-dependent and independent mechanisms Alzheimer's & Dementia. 2: S611-S611. DOI: 10.1016/J.Jalz.2006.05.2063 |
0.694 |
|
| 2006 |
Potter H, Boeras DI, Granic A, Padmanabhan J, Crespo NC, Crespo NC, Rojiani AM. P3-227: Chromosome aneuploidy, including human trisomy 21 caused by Alzheimer's mutant presenilin 1/ Î3
-secretase Alzheimer's & Dementia. 2: S442-S442. DOI: 10.1016/J.Jalz.2006.05.1496 |
0.728 |
|
| 2005 |
Potter H, Costa DA, Cracciola JR, Hughes T, Arendash GW. [O2-03-02]: Environmental enrichment prevents cognitive decline and induces memory-related gene expression in a mouse model of Alzheimer's disease Alzheimer's & Dementia. 1: S99-S99. DOI: 10.1016/J.Jalz.2005.06.343 |
0.651 |
|
| 2004 |
Costa DA, Nilsson LN, Bales KR, Paul SM, Potter H. Apolipoprotein is required for the formation of filamentous amyloid, but not for amorphous Abeta deposition, in an AbetaPP/PS double transgenic mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 6: 509-14. PMID 15505373 DOI: 10.3233/Jad-2004-6508 |
0.694 |
|
| 2004 |
Nilsson LN, Arendash GW, Leighty RE, Costa DA, Low MA, Garcia MF, Cracciolo JR, Rojiani A, Wu X, Bales KR, Paul SM, Potter H. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation. Neurobiology of Aging. 25: 1153-67. PMID 15312961 DOI: 10.1016/J.Neurobiolaging.2003.12.011 |
0.812 |
|
| 2004 |
Arendash GW, Garcia MF, Costa DA, Cracchiolo JR, Wefes IM, Potter H. Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport. 15: 1751-4. PMID 15257141 DOI: 10.1097/01.Wnr.0000137183.68847.4E |
0.689 |
|
| 2004 |
Leighty RE, Nilsson LN, Potter H, Costa DA, Low MA, Bales KR, Paul SM, Arendash GW. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition. Behavioural Brain Research. 153: 107-21. PMID 15219712 DOI: 10.1016/J.Bbr.2003.11.004 |
0.794 |
|
| 2004 |
Boeras DI, Granic A, Padmanabhan J, Potter H. P4-293 The presenilins, chromosome missegregation, and Alzheimer's disease Neurobiology of Aging. 25: S558. DOI: 10.1016/S0197-4580(04)81851-7 |
0.738 |
|
| 2004 |
Padmanabhan J, Potter H. P3-217 Aberrant mitosis specific protein phosphorylation in Alzheimer's disease Neurobiology of Aging. 25: S417. DOI: 10.1016/S0197-4580(04)81367-8 |
0.38 |
|
| 2004 |
Costa DA, Bales KR, Paul SM, Potter H. P2-302 Apolipoprotein E is required for filamentous, but not diffuse, amyloid deposition in an APP/PS mouse model of Alzheimer's disease Neurobiology of Aging. 25: S318-S319. DOI: 10.1016/S0197-4580(04)81047-9 |
0.674 |
|
| 2001 |
Potter H, Wefes IM, Nilsson LN. The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation. Neurobiology of Aging. 22: 923-30. PMID 11755000 DOI: 10.1016/S0197-4580(01)00308-6 |
0.475 |
|
| 2001 |
Nilsson LN, Das S, Potter H. Effect of cytokines, dexamethasone and the A/T-signal peptide polymorphism on the expression of alpha(1)-antichymotrypsin in astrocytes: significance for Alzheimer's disease. Neurochemistry International. 39: 361-70. PMID 11578771 DOI: 10.1016/S0197-0186(01)00043-2 |
0.387 |
|
| 2001 |
Nilsson LN, Bales KR, DiCarlo G, Gordon MN, Morgan D, Paul SM, Potter H. Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 1444-51. PMID 11222634 |
0.371 |
|
| 2001 |
Nilsson LNG, Bales KR, DiCarlo G, Gordon MN, Morgan D, Paul SM, Potter H. α-1-Antichymotrypsin Promotes β-Sheet Amyloid Plaque Deposition in a Transgenic Mouse Model of Alzheimer's Disease The Journal of Neuroscience. 21: 1444-1451. DOI: 10.1523/Jneurosci.21-05-01444.2001 |
0.45 |
|
| 2000 |
Potter H, Dressler D. The potential of BACE inhibitors for Alzheimer's therapy. Nature Biotechnology. 18: 125-6. PMID 10657070 DOI: 10.1038/72477 |
0.341 |
|
| 2000 |
Potter HP, Geller LN, Thomas AE, Conforto D, Chichkova RI. Cell cycle and chromosome segregation defects in alzheimer's disease Neurobiology of Aging. 21: 224. DOI: 10.1016/S0197-4580(00)83340-0 |
0.369 |
|
| 2000 |
Nilsson LN, DiCarlo G, Gordon MN, Morgan DG, Bales KR, Paul SM, Lilly E, Potter H. The role of alpha-1-antichymotrypsin (ACT) in abeta-amyloidosis of Alzheimer's disease, as studied in novel trigenic PDAPP, mapoe-knockout, GFAP-hACT transgenic mice strains Neurobiology of Aging. 21: 88. DOI: 10.1016/S0197-4580(00)82620-2 |
0.404 |
|
| 1999 |
Geller LN, Potter H. Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease. Neurobiology of Disease. 6: 167-79. PMID 10408806 DOI: 10.1006/Nbdi.1999.0236 |
0.427 |
|
| 1999 |
Rogers JT, Leiter LM, McPhee J, Cahill CM, Zhan SS, Potter H, Nilsson LN. Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences. The Journal of Biological Chemistry. 274: 6421-31. PMID 10037734 DOI: 10.1074/Jbc.274.10.6421 |
0.373 |
|
| 1999 |
Scinto LF, Rentz DM, Potter H, Daffner KR. Pupil assay and Alzheimer's disease: a critical analysis. Neurology. 52: 673-4. PMID 10025819 DOI: 10.1212/Wnl.52.3.673 |
0.362 |
|
| 1997 |
Li J, Xu M, Zhou H, Ma J, Potter H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell. 90: 917-27. PMID 9298903 DOI: 10.1016/S0092-8674(00)80356-6 |
0.329 |
|
| 1997 |
Kayyali US, Zhang W, Yee AG, Seidman JG, Potter H. Cytoskeletal changes in the brains of mice lacking calcineurin A alpha. Journal of Neurochemistry. 68: 1668-78. PMID 9084440 DOI: 10.1046/J.1471-4159.1997.68041668.X |
0.322 |
|
| 1996 |
Potter H. On keys and correlations in Alzheimer's disease Neurobiology of Aging. 17: 943-944. PMID 9363810 DOI: 10.1016/S0197-4580(96)00177-7 |
0.404 |
|
| 1996 |
Prihar G, Fuldner RA, Perez-Tur J, Lincoln S, Duff K, Crook R, Hardy J, Philips CA, Venter C, Talbot C, Clark RF, Goate A, Li J, Potter H, Karran E, et al. Structure and alternative splicing of the presenilin-2 gene. Neuroreport. 7: 1680-4. PMID 8904781 DOI: 10.1097/00001756-199607080-00031 |
0.33 |
|
| 1996 |
Ma J, Brewer HB, Potter H. Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides Neurobiology of Aging. 17: 773-780. PMID 8892351 DOI: 10.1016/0197-4580(96)00112-1 |
0.408 |
|
| 1996 |
Potter H, Geller LN. Alzheimer's disease, Down's syndrome, and chromosome segregation [17] Lancet. 348: 66. PMID 8691961 DOI: 10.1016/S0140-6736(05)64399-1 |
0.355 |
|
| 1996 |
Potter H, Ma J, Li J, Geller L, Kayyali U, Zhon H, Xu M, Zhang S, Nilsson P, Dressler D, Zhang W, Seidman J. 760 Involvement of ACT, apoE, AD3/PS-1, AD4/PS-2, trisomy 21, and calcineurin in the development of amyloid deposits, neurofibrillary tangles and neurodegeneration in Alzheimer's disease Neurobiology of Aging. 17: S188-S189. DOI: 10.1016/S0197-4580(96)80762-7 |
0.467 |
|
| 1996 |
Li J, Ma J, Zhou H, Xu M, Nilsson P, Potter H. 54 Study of the AD3 and AD4 familial Alzheimer's disease genes Neurobiology of Aging. 17: S14. DOI: 10.1016/S0197-4580(96)80056-X |
0.308 |
|
| 1995 |
Li J, Ma J, Potter H. Identification and expression analysis of a potential familial Alzheimer disease gene on chromosome 1 related to AD3 Proceedings of the National Academy of Sciences of the United States of America. 92: 12180-12184. PMID 8618867 DOI: 10.1073/Pnas.92.26.12180 |
0.408 |
|
| 1995 |
Das S, Potter H. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1 Neuron. 14: 447-456. PMID 7857652 DOI: 10.1016/0896-6273(95)90300-3 |
0.411 |
|
| 1994 |
Scinto LF, Daffner KR, Dressler D, Ransil BI, Rentz D, Weintraub S, Mesulam M, Potter H. A potential noninvasive neurobiological test for Alzheimer's disease. Science (New York, N.Y.). 266: 1051-4. PMID 7973660 DOI: 10.1126/Science.7973660 |
0.417 |
|
| 1994 |
Ma J, Yee A, Brewer HB, Das S, Potter H. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments Nature. 372: 92-94. PMID 7969426 DOI: 10.1038/372092A0 |
0.425 |
|
| 1993 |
Nelson RB, Siman R, Iqbal MA, Potter H. Identification of a chymotrypsin-like mast cell protease in rat brain capable of generating the N-terminus of the Alzheimer amyloid β-protein Journal of Neurochemistry. 61: 567-577. PMID 8336143 DOI: 10.1111/J.1471-4159.1993.Tb02160.X |
0.383 |
|
| 1992 |
Potter H, Nelson RB, Das S, Siman R, Kayyali US, Dressler D. The involvement of proteases, protease inhibitors, and an acute phase response in Alzheimer's disease Annals of the New York Academy of Sciences. 674: 161-173. PMID 1288361 DOI: 10.1111/J.1749-6632.1992.Tb27485.X |
0.342 |
|
| 1992 |
Potter H. The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease Progress in Brain Research. 94: 447-458. PMID 1287729 DOI: 10.1016/S0079-6123(08)61772-0 |
0.422 |
|
| 1991 |
Abraham CR, Driscoll J, Potter H, Van Nostrand WE, Tempst P. A calcium-activated protease from Alzheimer's disease brain cleaves at the N-terminus of the amyloid beta-protein. Biochemical and Biophysical Research Communications. 174: 790-6. PMID 1993072 DOI: 10.1016/0006-291X(91)91487-W |
0.614 |
|
| 1991 |
Koo EH, Abraham CR, Potter H, Cork LC, Price DL. Developmental expression of alpha 1-antichymotrypsin in brain may be related to astrogliosis. Neurobiology of Aging. 12: 495-501. PMID 1837594 DOI: 10.1016/0197-4580(91)90079-Y |
0.625 |
|
| 1990 |
Abraham CR, Shirahama T, Potter H. Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin. Neurobiology of Aging. 11: 123-9. PMID 2190106 DOI: 10.1016/0197-4580(90)90045-2 |
0.638 |
|
| 1989 |
Abraham CR, Selkoe DJ, Potter H, Price DL, Cork LC. Alpha 1-antichymotrypsin is present together with the beta-protein in monkey brain amyloid deposits. Neuroscience. 32: 715-20. PMID 2689908 DOI: 10.1016/0306-4522(89)90292-3 |
0.7 |
|
| 1989 |
Abraham CR, Potter H. The protease inhibitor, alpha 1-antichymotrypsin, is a component of the brain amyloid deposits in normal aging and Alzheimer's disease. Annals of Medicine. 21: 77-81. PMID 2669847 DOI: 10.3109/07853898909149188 |
0.635 |
|
| 1989 |
Abraham CR, Potter H. Alpha 1-antichymotrypsin in brain aging and disease. Progress in Clinical and Biological Research. 317: 1037-48. PMID 2513582 |
0.588 |
|
| 1989 |
Pasternack J, Abraham C, Dyke BV, Potter H, Younkln S. ASTROCYTES IN ALZHEIMERʼS DISEASE GRAY MATTER EXPRESS α1 ANTICHYMOTRYPSIN mRNA Journal of Neuropathology and Experimental Neurology. 48: 328. DOI: 10.1097/00005072-198905000-00087 |
0.537 |
|
| 1989 |
Abraham CR, Potter H. Alzheimer's disease: Recent advances in understanding the brain amyloid deposits Bio/Technology. 7: 147-153. DOI: 10.1038/Nbt0289-147 |
0.644 |
|
| 1988 |
Abraham CR, Selkoe DJ, Potter H. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 52: 487-501. PMID 3257719 DOI: 10.1016/0092-8674(88)90462-X |
0.69 |
|
| 1988 |
ABRAHAM CR, SELKOE DJ, POTTER H. ??1-ANTICHYMOTRYPSIN IN BRAIN AGING AND DISEASE Alzheimer Disease & Associated Disorders. 2: 259. DOI: 10.1097/00002093-198802030-00108 |
0.638 |
|
| Show low-probability matches. |